Loring Wolcott & Coolidge Fiduciary Advisors’s Cognex CGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-69
Closed -$3.25K 601
2022
Q4
$3.25K Hold
69
﹤0.01% 543
2022
Q3
$3K Hold
69
﹤0.01% 567
2022
Q2
$3K Hold
69
﹤0.01% 591
2022
Q1
$5K Hold
69
﹤0.01% 584
2021
Q4
$5K Sell
69
-52
-43% -$4.2K ﹤0.01% 649
2021
Q3
$10K Hold
121
﹤0.01% 584
2021
Q2
$10K Buy
+121
New +$9.79K ﹤0.01% 627
2021
Q1
Sell
-69
Closed -$6K 376
2020
Q4
$6K Sell
69
-750
-92% -$54.5K ﹤0.01% 665
2020
Q3
$53K Buy
819
+69
+9% +$4.46K ﹤0.01% 392
2020
Q2
$45K Buy
+750
New +$40.7K ﹤0.01% 385
2018
Q1
Sell
-800
Closed -$49K 733
2017
Q4
$49K Hold
800
﹤0.01% 436
2017
Q3
$44K Buy
+800
New +$40.6K ﹤0.01% 436

Other funds holding CGNX

Loring Wolcott & Coolidge Fiduciary Advisors's CGNX Position: Q1 2023 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Cognex (CGNX) in Q1 2023, closing a stake of 69 shares — an estimated $3.25K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in CGNX in Q3 2017 and held it in 12 quarters. The position peaked at $53K in Q3 2020. 484 funds tracked by Wall St. Rank hold CGNX as of Q1 2023.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Cognex position as of Q1 2023 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 69 Cognex shares in Q1 2023, an estimated $3.25K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Cognex in Q3 2017 and held it in 12 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Cognex position peaked at $53K in Q3 2020.
  • 484 funds tracked by Wall St. Rank held Cognex as of Q1 2023.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2023, filed 2 May 2023.